+1-888-308-5802     
News Contact Us

Carcinoembryonic Antigen Market 2020 Regional Growth Drivers, Opportunities, Trends, and Forecasts to 2024

Author : Ronak Bora | Published Date : 2020-09-18 

Carcinoembryonic Antigen Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

Carcinoembryonic antigen (CEA) is a type of protein that is normally present at very low levels in the blood and CEA tests are being used in diagnosing and managing certain kinds of cancers. The introduction of several government initiatives to grow awareness among people regarding early detection of cancer will boost demand for carcinoembryonic antigen tests.

According to a multicenter retrospective study, the clinical significances of positive postoperative serum CEA and post-preoperative CEA increment in stage II and III colorectal cancer is quite evident. Carcinoembryonic antigen is the most common serum tumor marker in colorectal cancer (CRC). As per GMI,  global carcinoembryonic antigen market size will reach over US$3 billion mark by 2024.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/427

Carcinoembryonic antigen test applications are broadly used in the diagnosis of several cancerous conditions including lung cancer, prostate cancer, ovarian cancer, breast cancer, thyroid cancer, and gastrointestinal cancer. Rising demand effective cancer screening services and the growing prevalence of cancer patients will foster market growth.

Reportedly, nearly 8.2 million deaths out of 14.1 million new cancer cases were recorded in 2013. Also, the percentage of breast cancer stands at 11.9% out of all forms of cancer globally, amounting to 1.7 million cases in total. On account of the soaring number of deaths among women having breast cancer, leading to escalating demand for early cancer diagnosis, the breast cancer segment is projected to grow at a considerable rate of 7.3% CAGR through 2024.

The growing prevalence of unhealthy lifestyle and increasing trend of drinking alcohol, smoking, and obesity are prime factors for the share of males in the carcinoembryonic antigen market which was valued at nearly US$1 million in 2017. As per the NHS UK, 16% of males are more likely to develop cancer and nearly 40% of males are more likely to die from cancer as compared with women.

Numerous hospitals are increasingly adopting technologically advanced carcinoembryonic antigen tests that are being used for diagnosing cancer. On account of the increased elderly population suffering from cancer, the hospital segment in carcinoembryonic antigen industry is expected to rise significantly at a CAGR of 6.1% up to 2024.

The escalating trend of unhealthy food habits and erratic lifestyle leading to obesity and growing incidences of diabetes has increased the number of cancer patients. As per Cancer Research UK, it is projected that there will 27.5 million new cancer cases each year by 2040 globally. The accelerating prevalence of cancer in most of the emerging countries is one of the prime factors the demand for carcinoembryonic antigen.

On the other hand, growing expenditure to advance healthcare infrastructure, technology-driven R&D in medical science, and rapidly increasing geriatric population are factors fostering U.K. carcinoembryonic antigen industry share, which is anticipated to grow at a considerable CAGR of 6.7% in the coming years.

Prominent companies in the industry are Boster Biological Technology, GenWay Biotech Inc., Omega Diagnostics Group PLC, Correlogic Systems, Inc., RayBiotech, Inc., Creative Diagnostics, Quest Diagnostics, and F. Hoffmann-La Roche Ltd. These organizations leverage strategic planning such as new product development, collaborations, and partnerships to gain a competitive advantage. 

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/carcinoembryonic-antigen-cea-market-report

Partial Chapter of the Table of Content 

Chapter 4.     Carcinoembryonic Antigen Market, By Application

4.1. Global carcinoembryonic antigen market share, by application, 2017 & 2024

4.2. Gastrointestinal Cancer

4.2.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.2.  Colon Cancer

4.2.2.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.3.  Pancreatic Cancer

4.2.3.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.4.  Rectal Cancer

4.2.4.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.5.  Liver Cancer

4.2.5.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.6.  Stomach Cancer

4.2.6.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.7.  Esophageal Cancer

4.2.7.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.8.  Gallbladder Cancer

4.2.8.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.2.9.  Anal Cancer

4.2.9.1.    Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.3. Breast Cancer

4.3.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.4. Lung Cancer

4.4.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.5. Ovarian Cancer

4.5.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.6. Prostate Cancer

4.6.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

4.7. Thyroid Cancer

4.7.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

Chapter 5.     Carcinoembryonic Antigen Market, By Gender

5.1. Global carcinoembryonic antigen market share, by gender, 2017 & 2024

5.2. Male

5.2.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

5.3. Female

5.3.1.  Market estimates and forecast, by region, 2013 – 2024 (USD Million)

 

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

Positron Emission Tomography Market To Witnessed An Appreciable Growth By 2026

Published Date: 2020-11-30         Author: Ronak Bora

Tentatively called ‘Global Positron Emission Tomography Market Research Report’, has compiled the report having undertaken extensive research and providing an in-depth evaluation of the global market. The report is basically inclusive of a detailed study of this market in combination wit... Read More

Medical Imaging Workstations Market Is Predicted to Witness A Massive Growth Up To 2026

Published Date: 2020-11-30         Author: Ronak Bora

An inherent blend of vital market definitions, the medical imaging workstations market report comprises details pertaining to the overall scope of the industry, pivotal insights, and parameters such as the industry ecosystem analysis, growth drivers responsible for fueling the commercialization matr... Read More

Surgical Devices Market Revenue & Regional Analysis Forecast to 2026

Published Date: 2020-11-30         Author: Ronak Bora

The research report on surgical devices market, in substance, presents an exclusive understanding of the vast expanse of the business space in question. The report comprises a gist of the industry by means of providing an executive summary, industry insights, industry ecosystem analysis, market segm... Read More

© 2020 Fractovia. All Rights Reserved